Accentis N.V.
Accentis N.V. (ACCB.BR) Financial Performance & Income Statement Overview
Analyze Accentis N.V. (ACCB.BR) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Accentis N.V. (ACCB.BR) Income Statement & Financial Overview
View the income breakdown for Accentis N.V. ACCB.BR across both annual and quarterly reports.
| Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
|---|---|---|---|---|
| Revenue | $3.23M | $3.15M | $3.32M | $3.66M |
| Cost of Revenue | $970000.00 | $865000.00 | $943000.00 | $1.49M |
| Gross Profit | $2.26M | $2.28M | $2.38M | $2.17M |
| Gross Profit Ratio | $0.70 | $0.73 | $0.72 | $0.59 |
| R&D Expenses | $0.00 | $0.00 | $258000.00 | $58000.00 |
| SG&A Expenses | $270000.00 | $0.00 | $3000.00 | $0.00 |
| Operating Expenses | $270000.00 | $3.88M | $1.08M | $1.94M |
| Total Costs & Expenses | -$1.24M | $3.88M | $1.20M | $1.72M |
| Interest Income | $221000.00 | $0.00 | $258000.00 | $58000.00 |
| Interest Expense | $0.00 | $0.00 | $461000.00 | $488000.00 |
| Depreciation & Amortization | $3000.00 | $3000.00 | $3000.00 | -$1.96M |
| EBITDA | $1.99M | $2.00M | $2.12M | $1.94M |
| EBITDA Ratio | $0.62 | $0.64 | $0.64 | $0.53 |
| Operating Income | $1.99M | -$732000.00 | $2.12M | $1.94M |
| Operating Income Ratio | $0.62 | -$0.23 | $0.64 | $0.53 |
| Other Income/Expenses (Net) | -$1.37M | $1.31M | -$82000.00 | -$653000.00 |
| Income Before Tax | $624000.00 | $575000.00 | $2.04M | $1.29M |
| Income Before Tax Ratio | $0.19 | $0.18 | $0.61 | $0.35 |
| Income Tax Expense | $332000.00 | $88000.00 | $511000.00 | $209000.00 |
| Net Income | $292000.00 | $487000.00 | $1.53M | $1.08M |
| Net Income Ratio | $0.09 | $0.15 | $0.46 | $0.29 |
| EPS | $0.00 | $0.00 | $0.001 | $0.001 |
| Diluted EPS | $0.00 | $0.00 | $0.001 | $0.001 |
| Weighted Avg Shares Outstanding | $1.26B | $1.26B | $1.26B | $1.26B |
| Weighted Avg Shares Outstanding (Diluted) | $1.26B | $1.26B | $1.26B | $1.26B |
The company's financials show resilient growth, with revenue advancing from $3.66M in Q2 2023 to $3.23M in Q4 2024. Gross profit remained healthy with margins at 70% in Q4 2024 compared to 59% in Q2 2023. Operating income hit $1.99M last quarter, sustaining a consistent 62% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $1.99M. Net income dropped to $292000.00, while earnings per share reached $0.00. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan